Nigeria
Celltrion’s regdanvimab shows neutralising potency against Covid-19
Celltrion’s regdanvimab (CT-P59) shows neutralising potency against emerging Covid-19 virus variants.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox